⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL28286894 | 0.89 | LMNA (0.53) | — | |
| Acetamide SCHEMBL6731735 | 0.83 | — | — | |
| Acetone SCHEMBL8887669 | 0.82 | — | — | |
| Urea SCHEMBL1312661 | 0.82 | — | — | |
| Acetamide SCHEMBL4953249 | 0.82 | LMNA (1.00) | — | |
| Acetamide SCHEMBL20411642 | 0.82 | — | — | |
| Acetamide SCHEMBL20411647 | 0.82 | — | — | |
| Acetamide SCHEMBL20411649 | 0.82 | — | — | |
| Acetamide SCHEMBL6278917 | 0.82 | — | — | |
| Acetamide SCHEMBL2232674 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4482841-A1 | THIENOPYRROLOTRIAZINE COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE | Sanofi (FR) | 2025-01-01 | — | — | EP | claimed |
| US-20240270748-A1 | TRICYCLIC HETEROCYCLES | MERCK PATENT GMBH (DE) | 2024-08-15 | — | — | US | claimed |
| CN-116920747-A | Synthetic device system and synthetic method of methylethylamine | 天津绿菱气体有限公司 | 2023-10-24 | — | — | CN | claimed |
| WO-2023156643-A1 | THIENOPYRROLOTRIAZINE COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE | SANOFI (FR) | 2023-08-24 | — | — | WO | claimed |
| EP-4168407-A1 | BRAF DEGRADERS | C4 Therapeutics, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| WO-2021255212-A1 | BRAF DEGRADERS | F. HOFFMANN-LA ROCHE AG (CH) | 2021-12-23 | — | — | WO | claimed |
| CN-102206216-A | Pyrrolo[2,3-B] pyridine derivatives as protein kinase inhibitors | PLEXXIKON INC | 2011-10-05 | — | — | CN | claimed |
| CN-102203280-A | Diacylglycerol acyltransferase inhibitors | VIA PHARMACEUTICALS INC | 2011-09-28 | — | — | CN | claimed |
| US-20250230147-A1 | LACTAMS AS CBL-B INHIBITORS | GENENTECH, INC. (US) | 2025-07-17 | — | — | US | disclosed |
| US-20250197406-A1 | INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME | 1ST Biotherapeutics, Inc. (KR) | 2025-06-19 | — | — | US | disclosed |
| CN-115335373-B | Compounds and uses thereof | 福宏治疗公司 | 2025-05-20 | — | — | CN | disclosed |
| US-20250129091-A1 | THIENOPYRROLOTRIAZINE COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE | SANOFI (FR) | 2025-04-24 | — | — | US | disclosed |
| CN-119638700-A | NSD2 degradation agent and application thereof | 中科中山药物创新研究院 | 2025-03-18 | — | — | CN | disclosed |
| CN-113924092-B | Quinoline and quinazoline compounds and methods of use thereof | 斯汀格瑞治疗股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-102203280-A | Diacylglycerol acyltransferase inhibitors | VIA PHARMACEUTICALS INC | 2011-09-28 | — | — | CN | disclosed |
| CN-1662498-A | Novel tetrahydropyridine derivatives as renin inhibitors | ACTELION PHARMACEUTICALS LTD (CH) | 2005-08-31 | — | — | CN | disclosed |
| US-20050153401-A1 | Process for preparing optically active beta-aminocarboxylic acids from racemic n-acylated beta-aminocarboxylic acids | DEGUSSA AG (DE) | 2005-07-14 | — | — | US | disclosed |
| CN-1478084-A | Compounds useful in treatment of inflammatory diseases | — | 2004-02-25 | — | — | CN | disclosed |
| CN-1037501-A | Transform the method that acetylene is made vinylchlorid by hydrogenchloride | HUELS CHEMISCHE WERKE AG (DE) | 1989-11-29 | — | — | CN | disclosed |
| US-4699999-A | REMOVAL OF COBALT CATALYSTS BY NEUTRALIZATION | DYNAMIT NOBEL AG (DE) | 1987-10-13 | — | — | US | disclosed |